Every drug begins its journey to the clinic with preclinical testing to help predict whether the compound will work and if there is any risk to the patient. One required aspect of this risk assessment is to look for potential drug-drug interactions (DDI). This ebook will explore the regulatory expectations of drug developers to research DDI potential, the relationship between a drugâ€™s characteristics and DDI risk, the methods available to test those characteristics, and considerations for drug developers to plan and successfully navigate DDI risk assessment.
- Understand the regulatory expectations for drug developers with respect to drug-drug interaction studies, particularly in the investigational new drug application process.
- Understand the relationship between a drugâ€™s absorption, distribution, metabolism, and excretion (ADME) characteristics and the risk for drug-drug interactions.
- Learn about the methods available for testing drug characteristics that could impact the risk for drug-drug interactions.